Safety really comes down to proper dosing and patient selection by a licensed provider. A 2025 review that assessed the safety profiles of both drugs found that the most common adverse effects are the same for both tirzepatide and semaglutide, namely, nausea, vomiting and diarrhea
Some peptides support fat loss and body composition, while others enhance recovery, skin elasticity, cognitive clarity, or hormone balance
Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology
Consider switching to PlexusDx's monthly compounded semaglutide model if managing expiration dates and storage logistics feels overwhelming
The FDA does not conduct premarket review for compounded drugs to evaluate their safety, effectiveness, or quality